SFXN4
Basic information
Region (hg38): 10:119140767-119165714
Links
Phenotypes
GenCC
Source:
- growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome (Supportive), mode of inheritance: AR
- growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome (Moderate), mode of inheritance: AR
- growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome (Strong), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 18 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Hematologic; Neurologic | 24119684 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (74 variants)
- Inborn_genetic_diseases (43 variants)
- not_specified (15 variants)
- Growth_and_developmental_delay-hypotonia-vision_impairment-lactic_acidosis_syndrome (13 variants)
- SFXN4-related_disorder (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SFXN4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000213649.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | 21 | ||||
missense | 35 | 13 | 48 | |||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 7 | 7 | 36 | 30 | 4 |
Highest pathogenic variant AF is 0.0000501884
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SFXN4 | protein_coding | protein_coding | ENST00000355697 | 14 | 24901 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.24e-7 | 0.946 | 125688 | 0 | 60 | 125748 | 0.000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.765 | 156 | 185 | 0.842 | 0.00000955 | 2172 |
Missense in Polyphen | 31 | 44.446 | 0.69748 | 532 | ||
Synonymous | 0.326 | 64 | 67.4 | 0.949 | 0.00000371 | 626 |
Loss of Function | 1.90 | 15 | 25.3 | 0.592 | 0.00000149 | 265 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000448 | 0.000426 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000587 | 0.000554 |
European (Non-Finnish) | 0.000223 | 0.000211 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000327 | 0.000327 |
Other | 0.000374 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Potential iron transporter. {ECO:0000250}.;
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 18 (COXPD18) [MIM:615578]: An autosomal recessive disorder of mitochondrial dysfunction characterized by intrauterine growth retardation, hypotonia, visual impairment, speech delay, and lactic acidosis associated with decreased mitochondrial respiratory chain activity. Affected patients may also show hematologic abnormalities, mainly macrocytic anemia. {ECO:0000269|PubMed:24119684}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0633
Intolerance Scores
- loftool
- rvis_EVS
- -0.71
- rvis_percentile_EVS
- 14.4
Haploinsufficiency Scores
- pHI
- 0.0456
- hipred
- N
- hipred_score
- 0.281
- ghis
- 0.583
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.796
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sfxn4
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Zebrafish Information Network
- Gene name
- sfxn4
- Affected structure
- nucleate erythrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- ion transmembrane transport;iron ion homeostasis
- Cellular component
- mitochondrial inner membrane;integral component of membrane;intracellular membrane-bounded organelle
- Molecular function
- ion transmembrane transporter activity